Anhedonia
81
19
24
42
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
15 trials with published results (19%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.7%
3 terminated out of 81 trials
93.3%
+6.8% vs benchmark
14%
11 trials in Phase 3/4
36%
15 of 42 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 42 completed trials
Clinical Trials (81)
Reward Processing and Exposure Therapy for Social Anxiety Disorder
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
Positive Affect Treatment for Spanish-Speaking Individuals
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Get ActivE Study for At-risk Youth
Anhedonia, Development, and Emotions: Phenotyping and Therapeutics
A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure
Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide
Prevention of Anhedonia in Children
Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression
A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant
A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
Individualized Neuromodulation for Anhedonic Depression
A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents
Dopaminergic Therapy for Anhedonia - 2
Sleep and Healthy Aging Research on Depression for Younger Women
Psilocybin for Treatment-Resistant Depression
Optimizing a Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents
Ecological Momentary Intervention for Reward in Anhedonia